Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.NewcelX and Eledon partner for NCEL-101 programme
Tegoprubart is a monoclonal antibody developed to regulate immune pathways in transplant rejection. Credit: Corona Borealis Studio / Shutterstock.com.
Tegoprubart is a monoclonal antibody developed to regulate immune pathways in transplant rejection. Credit: Corona Borealis Studio / Shutterstock.com.